Company profile
Passage Bio
Our mission is to improve the lives of patients with neurodegenerative diseases
- Industry
- Biotechnology Research
- Employees
- 43
- Headquarters
- Philadelphia, Pennsylvania
- Founded
- 2017
- LinkedIn followers
- 15,945
- Office locations
- 1
Passage Bio company summary
Passage Bio is a company in the Biotechnology Research industry, headquartered in Philadelphia, Pennsylvania, founded in 2017. On LinkedIn the company has around 43 employees and 15,945 followers.
What technology does Passage Bio use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Passage Bio
We are a clinical stage genetic medicines company on a mission to improve the lives of patients with neurodegenerative diseases. Our primary focus is the development and advancement of cutting-edge, one-time therapies designed to target the underlying pathology of these conditions. Our lead product candidate, PBFT02, seeks to treat neurodegenerative conditions, including frontotemporal dementia, by elevating progranulin levels to restore lysosomal function and slow disease progression. Our team's unwavering commitment to excellence is the driving force behind our mission to protect patients and their families against loss in neurodegenerative conditions.
Where is Passage Bio located?
Passage Bio lists 1 location.
Compare companies similar to Passage Bio
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Passage Bio passagebio.com | Biotechnology Research | 43 | 2017 | Philadelphia, Pennsylvania |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Passage Bio
What does Passage Bio do?
We are a clinical stage genetic medicines company on a mission to improve the lives of patients with neurodegenerative diseases. Our primary focus is the development and advancement of cutting-edge, one-time therapies designed to target the underlying pathology of these conditions. Our lead product candidate, PBFT02, seeks to treat neurodegenerative conditions, including frontotemporal dementia, by elevating progranulin levels to restore lysosomal function and slow disease progression. Our team's unwavering commitment to excellence is the driving force behind our mission to protect patients and their families against loss in neurodegenerative conditions.
How many employees does Passage Bio have?
Passage Bio has around 43 employees on LinkedIn.
Where is Passage Bio headquartered?
Passage Bio is headquartered in Philadelphia, Pennsylvania.
When was Passage Bio founded?
Passage Bio was founded in 2017.
Build a lead list from companies like Passage Bio
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.